NCT05246215View on ClinicalTrials.gov

Diagnostic Values of Galectin-3, Soluble ST2 and BNP in Predicting the Clinical Outcome of ST-Segment Elevation Myocardial Infarction Patients

Not yet recruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

December 1, 2025

Study Completion Date

March 1, 2026

Conditions
ST Elevation Myocardial InfarctionHF - Heart FailureStable Angina
All Listed Sponsors
lead

Assiut University

OTHER

NCT05246215 - Diagnostic Values of Galectin-3, Soluble ST2 and BNP in Predicting the Clinical Outcome of ST-Segment Elevation Myocardial Infarction Patients | Biotech Hunter | Biotech Hunter